Q2 2022 Performant Financial Corp Earnings Call
and welcome to the Performant Financial Corp second quarter 2022 earnings call.
At this time, all participants are in a listen-only mode.
A question and answer session will follow the formal presentation.
If anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad.
As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Richard Zubeck, Investor Relations. Please go ahead.
Thank you, operator. Good afternoon, everyone. By now, you should have received a copy of the earnings release for the company's second quarter 2022 results. If you have not, a copy is available on the investor relations portion of our website. On today's call will be Lisa M., chief executive officer, Demi and Cole, president, and Rohit Ramchandani, senior vice president of finance and strategy.
Before we begin, I'd like to remind you that some of the comments made on today's call, including our financial guidance, are forward-looking statements. These statements are subject to risks and uncertainties, including those described in the company's filings with the SEC. The results may differ materially from those described during the call.
In addition, all forward-looking statements are made as of today and the company does not undertake to update any forward-looking statements based on new circumstances or revised expectations. In addition, all forward-looking statements are made as of today and the company does not undertake to update any forward-looking statements based on new circumstances or revised
Also, all non-GAAP financial measures discussed during this call are reconciled to the most directly comparable GAAP measures in the table attached to our press release.
I would now like to turn the call over to Lisa M. Lisa?
Thank you, Rich. Good afternoon, everyone, and thank you for joining us for our earnings call. Our results in the second quarter were right where we thought they would be. Our enhanced efficiencies related to our technology platform, combined with our team's continued progress on expanding our commercial operations, has us well positioned for continued growth throughout 2022 and beyond. The winter COVID surge related to Omicron largely played out as anticipated in terms of ourExciting
services, outpatient services have eclipsed inpatient services. It is too early to tell, but this could be the new norm in the post-COVID world.
While we anticipate COVID will continue to remain with us for the foreseeable future,
At this time, we do not believe we will see a precipitous drop in core utilization rates this year as we did last year. Overall, we are pleased with the pace of our transition and our ability to continue to gain market share, which would not be possible without our incredible, hardworking key members.
Thank you again for your dedication and commitment to performance.
With that, I'll turn things over to Simi and Cole to discuss the second quarter and other initiatives in greater detail.
Tim?
Thanks Lisa and good afternoon everyone.
The second quarter of 2022 marks another quarter of strong year-over-year growth in our health care revenues.
Overall, for healthcare revenue in the second quarter, it was $21.8 million, an increase of approximately 17% when compared to the same period last year.
revenue from our claims and eligibility based offerings.
were up 26 and 13 percent respectively over the second quarter of last year.
Eligibility growth was tempered by some softness and recoveries within our government sector.
But of note, our newer MSP Advantage offerings in the commercial market
have shown great traction with 30% growth over the same quarter last year.
In addition, our eligibility inventory development in the first half of the year was strong, which we believe should set us up nicely for the second half of 2022.
Through the first half of the year, we have completed 10 new implementations.
We are working on a similar number for the second half.
And we have a number of new deals and contracting that will serve to bolster our implementation pipeline into 2023.
While excited about the growth of our sales pipeline and our ability to expand statements of work with existing clients,
We are also pursuing additional avenues of growth.
To that end, we are in discussions with two midsize payers to become their exclusive Enterprise Payment Integrity Partner.
The operative word is partner.
Different from the traditional vendor stack model, our highly customized approach allows us to design a comprehensive offering.
specifically tailored to meet the payer's unique needs.
We believe there are a significant number of similar opportunities among the small to mid-sized health plans.
and we are actively working to develop a roadmap for how best to expand this model.
This should lead to a faster penetration of wallet share while reducing the costs and risks of managing multiple payment integrity vendors for our client partners.
This ability to operationalize a highly customized end-to-end offering is exactly what we've been communicating in terms of our uniqueness.
And it's truly rewarding to see payers begin to recognize the same.
Looking ahead, we have a robust sales pipeline, which provides foundation to bolster long-term growth if we are able to convert these opportunities into implementations that flow through our onboarding and ramp-up cycles.
As I think about these opportunities and to Lisa's earlier comment, I would like to
People are at the core of everything we do. They are without a doubt our most valuable asset and what truly sets us apart from our competition.
Fostering a client-centric high performance culture has and will continue to be a vital priority. To that end, I am pleased to announce that Melissa Christ has joined Performant as Chief People Officer to lead this very important area of focus.
Melissa brings 20 plus years of experience in people strategy and working with high growth companies.
She understands what it takes to recruit and retain top talent.
And she has a great track record for developing highly engaged teams.
Melissa's addition rounds out an exceptionally talented leadership team, and we all look forward to working with her as we navigate the next phase of our growth.
In terms of the CMS RAC Region 2 protests,
The award continues to be under review by CMS.
We stand by the quality of our submission, as evidenced by the award, and the work that we currently do for CMS in Regions 1 and 5. We just have to allow for the procurement process to play itself out.
On a related note, the CMS MSP Recompete RFQ was recently issued, as expected.
We are in the process of responding and having produced record recoveries during our tenure as the incumbent, we are confident of our qualifications and ability to submit a qualified response.
Finally, on the topic of COVID,
As Lisa noted, we remain optimistic that the headwinds and related audit restrictions will continue to gradually abate, alongside a sustained rebound in core utilization.
As an encouraging sign, a handful of customers have begun to reverse limitations put in place due to COVID, but this remains on a very limited basis.
the majority of our customers are in a holding pattern as they wait to see what measures CMS will take on the matter. Regardless, even the limited activity is encouraging and allows us to better forecast expectations for 2023.
further and that we cannot fully predict the future of COVID.
We are aware of new variants that have been identified as being more contagious and more easily transmissible than OvaKronc.
A large outbreak could lead to a lower core utilization rate.
and possibly provider forbearance, which would be an impactful headwind.
But at this moment, we believe central impact is likely to be more constrained and largely staffing related.
which still could delay implementations with all recoveries, but we do not anticipate this to have a large-scale impact to our operations.
Overall, we are executing according to plan and we are reassured by our expanding sales pipeline. We believe we are well positioned to have a successful second half of the year and achieve our guidance targets for both revenue and ELA.
With that, I will hand it over to Rohit Ramchandani, our Senior VPAO Finance and Strategy to discuss the financials. Rohit? Hi everyone.
Thanks, Sim. As Sim mentioned, our results in the second quarter of 2022 were in line with our expectations, which accounted for a potential impact from the Omicron variant this past winter.
Overall, we reported total revenues of $25.7 million, which included healthcare revenues of $21.8 million.
or 17% increase as compared to our healthcare revenues from the second quarter of 2021.
We are also excited to note that on a trailing 12 month basis, healthcare revenues are currently north of $90 million.
Our total customer care outsourced services revenue for 3.9Million dollars for the quarter, which represented an increase of nearly 25% when compared to the 2nd quarter of last year. So, it's not our expectations remain unchanged given the continued pause in the federal suit loan payments, which are currently set to expire on August 31st of this year. Though we would be unsurprised if this pause is extended again.
Total non-healthcare recovery and revenue in the second quarter of 2022 was $7,000 in line with our anticipations of this stream going to zero.
Adjust EBITDA in the second quarter was a loss of $1.4 million compared to $4.2 million in the prior year period.
sequentially, we saw elevated operating expenses from some hiring catch-up as well as continued new contract implementations.
Claims-based, also known as claims auditing, revenues in the second quarter of 2022 were $9.3 million, or an increase of over 30% compared to the $7 million in the second quarter of 2021, representing growth from both new implementations as well as continued volume increases as existing statements of work move toward steady state.
We maintain our expectation to continue seeing a healthy growth trend for the claims-based revenues into the rest of 2022 based on the opportunities available to us.
Revenue from our eligibility based services for the second quarter was $12.4 million, representing roughly a 7% increase from the 11.6 million in the second quarter of 2021.
While we currently anticipate balance growth trends in all our healthcare product offerings over a multi-year span, we acknowledge and recognize that each year may look different.
Operating expenses in the second quarter were $29 million, which is roughly $5.1 million lower compared to the second quarter of last year. Similar to the first quarter, this decrease was primarily driven by decreases in operating expenses related to the cessation of activity within recovery markets, and offset by continued investment into our healthcare markets. Specifically, the addition of human capital, which we expect to increase our operating expenses and capital expenditure levels going forward.
Given no resolution of the RAC Region 2 protest as of yet, we still maintain a similar view on cash usage for 2022. This includes believing we have ample flexibility between cash on the balance sheet and revolver availability to pursue currently known and unknown organic investment opportunities.
We are pleased to be able to note this flexibility amidst its multious macroeconomic climate, which includes a number of companies that can be read about in the National Spotlight that are pausing hiring or even conducting layoffs. We are proud that we remain focused on the continued investment into technology and scale, and continue to be active in our own hiring efforts.
Given our continued achievements in the second quarter, building upon the first quarter, and in combination with the strong KPIs and opportunity growth ahead of us, we remain pleased with how we are tracking toward both the current year expectations and more importantly our long-term goals.
As we look ahead to the second half of the year, we are pleased to reiterate our health care revenue and overall company EBITDA guidances.
for 2022 of $92 to $96 million and $2 to $4 million, respectively.
By all accounts, this has been a strong start to the year, our long-term strategy remains intact and we are quite excited about the future. Operator, would you please open up the line for any questions?
Thank you. At this time, we will be conducting a question and answer session.
If you would like to ask a question, please press star and then one on your telephone keypad.
The confirmation turn will indicate your line is in the question queue.
You may press star and A2 if you would like to remove your question from the queue.
For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys.
One moment please while we pause for questions.
Our first question is from George Sutton of Greg Hallam. Just go ahead.
Thank you. Simeon, obviously the highlighted new information on the call is your discussion to be exclusive with a couple of mid-sized players. Can you just walk through how mature these discussions are, how these business models might evolve over time, just so we have some perspective? We just caused a little delay while getting to Robertourning on my phone. I'll let it
Yeah, happy to. We are in pretty advanced conversations on the topic, George. And look, as you think about it, right, I think as evidenced by the work we do for CMS.
and several national health plans. We have significant experience and obviously demonstrated success supporting kind of large scale program integrity engagements. And as we think about our flexible technology and some of the efficiencies that Lisa even mentioned in her opening remarks, it really does allow us to provide a kind of a similar end-to-end offering to mid-size plans. And so these plans get the benefit kind of a comprehensive solution that covers kind of all areas of plan spend.
So, you know, it's important to note as we think about all of that in context of the overhead. And complexities to manage multiple vendors, right? And especially for some of the mid to smaller plans that that really lack that infrastructure and staffing to do. So, so, um, look, as I, as I noted our prepared remarks, um, you know, we are in discussions with the 2 of these plans pretty advanced.
And they really do recognize the value in engaging.
kind of a single end-to-end solution. And so we're excited to see how it plays out. And our teams are already kind of planning on how we might think about changing some of our workflows, if you will, in terms of kind of onboarding. So kind of still a little bit in the early innings in terms of how we would actually onboard this and what the cadence would be. But I hope that gives you context in terms of why plans are looking at performance in terms of our capabilities and...
what we can do for them on their scale.
It would largely be people. It is always a combination. We use the technology behind the scenes to support everything that we do in terms of our end deliverable. But these two conversations that we are having right now are largely focused around the similar contingency services that we provide both in claims and eligibility in identifying the findings and then turning it over to the plans to recover.
So that's the initial conversation, but I think again, as our offering and our roadmap of products evolve, these really sticky opportunities, I think, give us an opportunity to have yet another channel for advancing those offerings.
One other thing, you mentioned a handful of customers have reversed limitations on COVID, but many are awaiting CMS guidance. I was not aware of the CMS guidance being a key factor here. Can you just explain that?...
Yeah, of course. So, look, as I think I've mentioned on a few of these calls, CMS definitely kind of sets the tone. And, again, I think that's a big part of what performance brings to the table to all of our customers and prospects is that we are closely aligned with CMS in our various RAC programs. And so your commercial payers tend to look for CMS. And what CMS does, especially as we think about Medicare Advantage plans, is they're
And so we do have a lot of the payers reaching out to us, asking for some insights, watching closely to see where CMS is going to go. I don't think, George, it's going to be any policy statement. It really is just if they see the WRAP program start evaluating those claims, and it gives them more comfort level to do so themselves. And so, as I noted in my prepared remarks, we are having conversations with a number of plans around the topic. We are seeing some plans actually in a limited basis.
start to actually start bringing in some of these claims for review. So that is very consistent with what I've been forecasting which is kind of Q3 Q4. We should have a pretty good consensus of where this is going to how it's going to unfold and what that impact is going to be for us in Q23 and beyond.
Understand. Very good. Thank you.
Sure.
Our next question is from Karl Bouser of Lake Street Capital Markets. Please go ahead.
Great thanks for taking my questions and for all the updates here. So, Sam, maybe I'll just follow up on your comments regarding the discussions with the 2 mid sized payer. So it sounds like the offering that you're considering is kind of more bespoke as opposed to kind of the SAS offerings. You're contemplating and focusing on for the smaller tier pairs.
Is that still the case? Do you do anticipate kind of this? This new offering for these mid sized pairs kind of rolling over into the smaller tier space, or is or is still kind of 2 separate buckets. You know, more automated play for the smaller payers and then the spoke services for the mid size.
I think the fast play opportunity which continues to be in development that we are working on here, we still have that targeted more towards those smaller entities. I do think mid-sized as well in terms of some of the capacity and capability that it offers. I think specific to these two opportunities, the call out here is that they are sizable enough that they would still follow that traditional model of kind of a multi-vendor approach.
If you can find a vendor that has a real end-to-end solution, is able to bring all of the audit capability, all the audit spend to the table and be able to provide services around that, a full suite of eligibility offerings, the ability to support non-par recoveries.
and do that and have that vendor also have the view of the national landscape as as performant does, that's pretty unique. And so that's what we've been trying to share in terms of some of our unique capabilities and then obviously a platform that allows us to really specifically tailor these offerings. And so that's starting to resonate. So we've had these conversations now for you know probably as long as that 12-18 month sales cycle.
But it's starting to resonate and we're starting to get some good traction. So I think that's really the distinction So Kyle as we think about that clearly if that does get further traction, you know It's just I think in many regards it just gives us as I said a greater share of that wallet even more quickly Because it's a one vendor solution versus the competitive multi-stack approach
No, got it. That makes sense. I appreciate that. And maybe switching over to the guidance rowhead, I appreciate the reiteration. Can you talk a little bit about how we should kind of model cadence, both in terms of kind of Q3 and Q4, and also eligibility versus claim based on, I'm assuming Q4.
will be the strongest and claims as well. I just kind of want to get your thoughts on that.
Yeah, no, I think you're thinking about it right. I think, as you know, we're providing annual events, but I think similar to previous years, we do expectfuneral assessments and offplays of, for example, early on inAP creatively, and that
The revenues to show strongest in Q4. So kind of a sequential step up would be logical there as you think about the two quarters. I also think that you'll see a like trend between the eligibility and the claims based. And perhaps kind of continuing on what you've seen in Q2 slightly stronger growth rate on the claims based side, at least for the near term.
Great, appreciate it. And maybe 1 more follow up 2 part for Sam.
Great to see the update for the hiring of Melissa chief people officer. Do you feel like you got kind of the appropriate? Leadership team underneath you, or you think there's an opportunity to add more roles and then secondly. I'm just kind of curious, are you seeing any other competitive headwinds out there? Hello quick question power out of our row that system,
or another peer play kind of similar to yourself with a smaller scale. Thank you. So the first part, I think Melissa really does round this out, right? So we have some fantastic operating leaders. We brought in some folks that from the payer space that they're helping us guide the product road map and support some of our our new offerings. And just as we've been growing and growing, as I noted, our people are our number one asset and driving the culture that I'm trying to accomplish here.
We're going up against the same players. I really haven't seen anyone yet, kind of other than the key ones that we've discussed emerge. So, I don't think there's a whole lot of change and we continue to do very well on that front.
Okay, appreciate it and congrats on all the updates.
Thank you.
Ladies and gentlemen, we have reached the end of the question and answer session, and I would like to turn the call back to management for any closing remarks.
Thank you, operator. We want to thank you for joining us today. We want to thank our clients always for allowing us to serve and partner with you. And of course, we want to thank our team members who bring your best to perform it every day. Thank you for your time and your attention today.
This concludes today's conference. Thank you for joining us. You may now disconnect your lines.
The.
Yeah.
The Form ment Al cour court cour the the nine tion Dec the form ation the conions the contr cour the confere, n the to ations Thank one the the companyy second courar two y two su not il re court of call expected officee cour courpresent present fin strate cour the state the cour uding anci cour state state sub Ks certain including those cour the the state from those cour cour addition all cour the state the companyy not under cour the state ST or reved expect also all Al discuss the cour re to the con and the able the call over to thank one joining cour the court the posion related our no Form bined our continue progress the commercial operation the ation continue cour two 20, 20 to and the the cour related to cour large the ated terms the Act to our the RE on cour ation the second courarter. We the the that we are court ation lawvel the. We are the ly that we have the the ation serv some case ation serv ation servic ly to the the the cour cour cour continue to re for the cour the ut year the not the court ation year last year. Overall are the the ation ability to ue to cour not pro courred courking Thank ation comm to form that the cour discuss the court su cour Thank second courtter two thousand 20 Ks courarter courth health reven overall health care revenue in second qucourarter the 20, one point eight mill cour pro se compared the last year revenue from our claim eleggiability Ed offerings: 20, six and pected over the second courarter of last year. leggiability, the by recover the our nment age offerings in the ercial cour cour tract per over the courarter last year. ition eleggiability in pment the first of the STR we believe for the second of two thousand and 20, two the first of the year we Ted implementations. We working simil number for the second and we have athe contract that the implementation ppeline thousand and 20 C about the cour of our alil pipeline. Ability to exp state ment of cour ex cions. We are also su ING ition venues of cour that weare dission to P ERS, the and partcouror O cour part or from the tritionional del custo the pro allowed the propre of offering the cific thep ERS. We believe significant number of ilar opportunities, the law M health planans. We courking P that the model, the tration of law year the cour lawulti ment for C partars the ability operation custo the and and offering Act what we ated inter of our and couring to re the. We have alil pipeline proved ation the law ter we able the opportunities, implementations that on boarding the these opportunities and ly the court two the part comtation C sent Form cour continue to orty that ple the ining Form ment officee believe the court 20 and strate cour King company under cour and re the cour TR for P the addition's out cept ion lead, ER and we all cour King the cour terms of the C's re two prot the cour continue to be under revie by C the coural our missation idence by the cour and the cour court do C M REG ions one we allowed ter ment pro the related the's re issu expected are in the process of P? Ing and have re recour our 10 the weare F of our law pectations and ability the the P F the cour. We re that the and related trations continue to law re court ations courag customers to re limmentations cour ue the cour the RE the limited case, the jor customers what C's on the ARD the limited TIV cour and allowed the cour C expectations for two thousand 20, three we not Prored the uture we are new that the the cour Trans MIS able cour large to lawer court ation provide cour Act believe sent Act ly to be more TR and large related. Still the implementation reco not have the Act our operations overall we are ut couring the plan. We are re by exp alil pipeline. We believe are ition have the second of the year the gu? Ar for both revenue that over strate discuss the financi. Thank mention su fromin the second courar of two thousand and 20, two line expectations coun tion from the the overall repcour total revenu two 20, five point seven mill included health revenue two 20, one point or per increase compared health revenue from the second qucourarter of two thousand and 20, one we are also that on health care revenu courrent ninein million dollars. Total custo services revenue three point nine million doll. The courarter re present increase 20, five compared to the second quarter year. Expectations re change in the continue in the Ed court thir. Last year we the, the POS, the not health reco revenue in the second quarter of and twent to two $7 line ations of in the second quarter the law one point four mill compared the four point two in the the cour leg ated oper sentens from some con continue TR ations claim case CLA ING revenues in the second quar two thousand 20 2, nine point three mill or increase over 30 compared in the seven mill in the second qucourar two thousand 20, one re present cour ations continue state the cour cour state exations contin he cour for the CLA revenu to the of two thousand and 20, two the opportun ail to revenue eligibility servic for the second quarter we point Form million dollars present re incre from the in the second quarter of 2020 one law court state cour CT re cour opering sentens in the second courarter or two 20, nine million doll re five point million compared in the second quarter last first courar the mill creases O ING sentens ated in the the tivity recocour and offset continueed vest Mar the cific ition of increase sentens the cour re solution of the two pro we still the ue C for two thousand and 20, two the believe ability C on the ailability courrently and or inv opport able the the ability courud the of companyy the national, our or are that we re the continue invest the and the continue cour in the second qucourarter ING the first courarter and commentation with the, the opp the ase the rent expectations cour court long the second the ase health revenue companyy two thousand 20 two 9, $6 million to formfour million doll expect coun STR to the year long terms re Act cour the year oper cour ations. Thank the the tion ition questionion the conformation the ion, the T to ion from the cour the cour tion titionation cour cour. Thank V the information. The call discussion couple of ERS continue discussions. These de law we have expected two we are conversation on the, on the cour and about think idence by the cour. Do C? M's, several national he planans. We signific ex and ated courorting pro ment and we about F? No, some of ition, that the, the ionions and re really Ed prov of the ilar and and offering M planans and the planans the, the pre's solion, the cour, all the cims, the ation ation, the legligiability, reco pro CT the, all the planans, and so we bin of our national ability, the clas and eleggiability landans, those national contract the cour, the com ING offering court about all that conte of the over and the ulti end CI the planans that that that struct to. So I not prop recourks are discussionions planans, cour and really do re the ue, the and and solation and C the and all planing on, we think, change some of our, the terms of on boarding still in the ly in terms of we would actually on cour the case, the con, in terms of planans cour, terms of our capability we do for their proveding the case large think the ation we, we the no, the the court that we do in terms of and the law, the conversation, that large CUs, the il continueed services that we prov cims, elegligiability and the, the cing. Turning over to theplanans recour, the itional conversation, I think the offering and procts law the, really the opportunities, that opportunity to two the for V C, those offerings one other ion customers of revers ations cour, C's guid, not of the C's gu fact C that court the, the think, mention the call the the we. I think that the cour Form ING to the able all of our cour mers pro pect that we closely line the C pro gr's and commercial P? Ers end the's. What C's we about? Age plan and we do law the ERS re out some course to C don't think or state really the pro gr's claims law do and so not remarks. We are conversation number planans, the are C some planans actually limited based to actually ING some claims for re what cour C? cour the sentens, what Act two y three tition, the ion D the F? Ard discuss So O contin, two con and for the year, ERS that the case, the opering P or or ated for the law P and for think I think the think that the opportunity continue to pment year. We have that AR Ed cour those the law think in terms of some the capability offers, I think, specific the to opportunities, the call year that the that that they would still law that tritional lawdel the lawulthe end prot cour to the end appro and he planans that do some of large ans court ING ING also Ed on law we of planans jority the ER 1, the the of ities and ING the ulti enders and finded the end and and solutionation. All the capability the, the able V services, that eleggiability offerings, the ability the court on reco RE and that have that also have the the the national Form ment cour that what we to two terms of some of our capability and then vious Form allowed really specific the offerings that re the conversation law that Al arding the ING the .traction, think that really the ion think about that that tract I ARD cour that law more courickly the one end solation vers petit proach pre ate that over to the gu preci ation ue lawdel terms for and also eleggiability vers claim for STR, claim 20 I think I il pect the revenues STR for the Al the law, the two courarter, ERS the that the eleggibility clas and continue to cour the CIM ated flaw two cour cour the the IR the off opportun and cour cour think the we have operating lead the P that he, the CT sucourt some of offerings and just ING the our number one and the that year vious ING AR just cour have some one the King anation I think really out terms of petit not not change in terms of our competit or cour y we continue to he peline opportunities ING the cers any one other the one that discuss cour Don think the law change, continue to law preciated D Thank contin have the questionion ation the.cour Thank oper joining our all law the cour court. Our mem ERS cour the form. Thank sent the ions ING the line.